Apo-semaglutide Injection : Incorrect Dose Display
Apo-Semaglutide injection pens are being recalled across Canada because the dose display on the device may show an incorrect amount of medication. This is a Class II recall, which means the product could cause temporary health problems or require medical intervention. The recall affects Apo-Semaglutide products distributed throughout Canada.
- Product
- Apo-Semaglutide
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-08-27
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/fc5f18e2-32c6-4bc9-ba99-bd4c99785410